Prostate cancer decisions — 2024

The Board has remanded the case due to an error in determining Agent Orange exposure, and will inquire if the Veteran was exposed between October 1966 and December 1966.

The Veteran's hypertension and prostate cancer are granted pursuant to the PACT Act.,The remaining claims for PTSD, erectile dysfunction, and service connection on a basis other than the PACT Act are remanded.

The Veteran's service connection claims for diabetes mellitus, prostate cancer, and PTSD have been granted. Diabetes mellitus and prostate cancer are presumed to be related to exposure to herbicides during service in Vietnam. PTSD is denied as there is no verifiable stressor.

The Board has decided that new evidence is not relevant to the claim of service connection for prostate cancer, and has remanded the issue of benign prostate hypertrophy.

The Veteran's death was caused by chronic obstructive pulmonary disease, which is not service-connected. The Board found that his other service-connected conditions did not contribute substantially or materially to his death.

The Veteran's service-connected disabilities, primarily the residuals of prostate cancer, have rendered him unemployable as of October 2, 2023. The Board finds in favor of the Veteran on this issue.

The Board has remanded the case due to an error in determining Agent Orange exposure, and will inquire if the Veteran was exposed between October 1966 and December 1966.

The Veteran's claim for service connection for prostate cancer, which he contends is due to contaminated water exposure during his active duty at MCAS Cherry Point, has been remanded due to a failure to verify the alleged exposure. The AOJ must attempt to confirm the Veteran's reported exposure and provide a formal finding if insufficient information exists.

The Board has restored service connection for prostate cancer as a separate and distinct disability, granted earlier effective dates for service connection and SMC, but denied a compensable rating for erectile dysfunction.

The Veteran's service-connected prostate cancer and depressive disorder have rendered him unable to secure or follow substantially gainful employment, warranting a TDIU.

The Veteran's prostate disability is rated at 60 percent, but no higher. The claims for increased ratings of diabetic peripheral neuropathy in the left and right lower extremities are granted.,The Veteran's bilateral hearing loss does not meet the criteria for a compensable rating.

The Veteran's service-connected disabilities, including hypertension and diabetes mellitus, have rendered him unable to secure and maintain substantially gainful employment since June 23, 2014.

The Board has granted service connection for prostate cancer, diabetes mellitus type II, and bladder cancer on a presumptive basis due to presumed exposure to herbicide agents. Service connection for kidney cancer is denied as there is no evidence linking the condition to service.

The Veteran's appeal for higher ratings for PTSD, hypertension, prostate cancer residuals, and a surgical scar status post-prostatectomy was denied. The initial rating for PTSD remains at 50 percent.

The Veteran's claims for service connection for prostate cancer, erectile dysfunction, and prostatectomy scars have been granted with effective dates of September 13, 2019.,SMC based on loss of use of a creative organ has also been granted with the same effective date.

The Veteran's residuals of bladder cancer and prostate cancer are rated at 20 percent from June 24, 2020. The disability is characterized by needing to change absorbent materials less than two times per day.

The Veteran's prostate disability is currently rated as 20 percent disabling, and the Board has found that an increased rating is not warranted.,The Veteran's ED is currently rated as noncompensable, and the Board has found that a compensable evaluation is not warranted.

The Board has remanded the Veteran's claims for service connection for a heart condition and prostate cancer, finding insufficient evidence to support presumptive service connection based on herbicide exposure in Korea. The Veteran is directed to provide additional information about his duty locations during service.

The Board has remanded the Veteran's claims for obstructive sleep apnea, prostate cancer with total prostatectomy residual voiding dysfunction, chronic adjustment disorder, and TDIU due to a duty to assist error. The issues are remanded for further development.

The Board denied the Veteran's request to restore a 100% rating for prostate cancer from July 1, 2024, as there was no evidence of active disease at that time.